查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1611217

人類胚胎幹細胞市場規模、佔有率、趨勢分析報告：按應用、地區、細分市場預測，2025-2030

Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

人類胚胎幹細胞市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計到2030年，全球人類胚胎幹細胞市場規模將達到40億美元，2025年至2030年複合年成長率為10.44%。 hESCs 技術由於其宿主-移植物組織相容性高，往往可用於人體組織工程。

發育潛力的維持，即所有三個生殖細胞層對衍生物的貢獻，是這些細胞的重要特徵。即使克隆誘導和長期未分化擴增後，這種能力仍能持續維持，從而促進攝取。

此外，這些細胞能夠表現高水平的鹼性磷酸酶（一種關鍵轉錄因子）和端粒酶。已發現這些因素對於維持細胞內的多功能至關重要。

此外，hESCs可以輕易地分化為神經元、神經細胞、少突膠質細胞和星狀細胞。上述特徵對於研究神經發生早期發生的事件序列很有用。

然而，使用來自可行胚胎的幹細胞充滿了倫理問題，因此科學家正在探索其他方法來創建ESC。其他方法包括誘導胚胎生殖細胞、來自死亡胚胎的幹細胞以及其他技術。

人類胚胎幹細胞市場報告亮點

  • 到2024年，再生醫學將以54.18%的佔有率佔據市場主導地位。再生醫學在治療多種疾病方面取得了重大進展。此外，源自人類胚胎的多功能細胞已成為生物醫學研究的焦點。
  • 幹細胞生物學研究領域預計將在預測期內表現出最高的複合年成長率。過去，多家生物製藥公司已經探索了幹細胞生物學的潛力。
  • 在強大的研究基礎設施機構和設施的支持下，北美的人類胚胎幹細胞將在 2024 年佔據市場主導地位。慢性病和遺傳疾病的增加對基因治療產生了巨大的需求。
  • 亞太地區人類胚胎幹細胞市場預計在預測期內將顯著成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 工業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 人類胚胎幹細胞市場：應用商業分析

  • 細分儀表板
  • 全球人類胚胎幹細胞市場應用變化分析
  • 2018-2030年全球人類胚胎幹細胞市場規模及趨勢分析（依應用）
  • 再生醫學
  • 幹細胞生物學研究
  • 組織工程
  • 毒性試驗

第5章 人類胚胎幹細胞市場：區域估算與趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲人類胚胎幹細胞市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲人類胚胎幹細胞市場，2018-2030年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 參與企業
  • 策略規劃
  • 2024 年企業市場分析
  • 參與企業概況
    • Thermo Fisher Scientific, Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Sartorius AG
    • PromoCell GmBH
    • Takara Bio
    • Lonza
    • Cellartis AB
    • ATCC
    • AcceGen
    • Cell Applications, Inc.
    • Bio-techne
Product Code: GVR-1-68038-394-2

Human Embryonic Stem Cells Market Growth & Trends:

The global human embryonic stem cells market size is expected to reach USD 4.00 billion by 2030, registering to grow at a CAGR of 10.44% from 2025 to 2030 according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Human Embryonic Stem Cells Market Report Highlights:

  • Regenerative medicines dominated the market with a share of 54.18% in 2024. Regenerative medicines offer significant advancements in treating several diseases. Moreover, pluripotent cells originating from human embryos have been central to biomedical research.
  • The stem cell biology research segment will witness the highest CAGR over the forecast period. Several biopharmaceutical companies have explored the potency of stem cell biology in the past.
  • North America human embryonic stem cells dominated the market in 2024 owing to robust research infrastructure institutions and facilities. The rise in chronic diseases and genetic disorders has created a huge demand for gene therapies.
  • Asia Pacific human embryonic stem cell market is anticipated to witness significant growth in the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Application
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Embryonic Stem Cells Market: Application Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Human Embryonic Stem Cells Market Application Movement Analysis
  • 4.3. Global Human Embryonic Stem Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Regenerative Medicine
    • 4.4.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Stem Cell Biology Research
    • 4.5.1. Global Stem Cell Biology Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Tissue Engineering
    • 4.6.1. Global Tissue Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Toxicology Testing
    • 4.7.1. Global Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis by Application

  • 5.1. Regional Dashboard
  • 5.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. North America Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Scenario
      • 5.3.4.4. Mexico Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Denmark
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Denmark Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.8. Sweden
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Sweden Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Norway Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Japan Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. China
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. China Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. South Korea Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Australia
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Australia Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. Thailand Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Scenario
      • 5.6.2.4. Brazil Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Scenario
      • 5.6.3.4. Argentina Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Scenario
      • 5.7.2.4. South Africa Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Scenario
      • 5.7.3.4. Saudi Arabia Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Scenario
      • 5.7.4.4. UAE Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Scenario
      • 5.7.5.4. Kuwait Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Position Analysis, 2024
  • 6.4. Participant's Overview
    • 6.4.1. Thermo Fisher Scientific, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. STEMCELL Technologies
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Merck KGaA
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Sartorius AG
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. PromoCell GmBH
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Takara Bio
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Lonza
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Cellartis AB
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. ATCC
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. AcceGen
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Cell Applications, Inc.
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. Bio-techne
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Human Embryonic Stem Cells Market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 14 France Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 17 Denmark Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Sweden Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 19 Norway Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Japan Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 23 China Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 24 India Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 25 South Korea Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 26 Australia Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 27 Thailand Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 28 LATAM Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 29 LATAM Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Brazil Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 32 MEA Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 33 MEA Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 38 Participant's overview
  • Table 39 Financial performance
  • Table 40 Key companies undergoing expansions
  • Table 41 Key Companies Undergoing Acquisitions
  • Table 42 Key Companies Undergoing Collaborations
  • Table 43 Key companies launching new products
  • Table 44 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Human Embryonic Stem Cells Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Human Embryonic Stem Cells Market Driver Analysis
  • Fig. 12 Human Embryonic Stem Cells Market Restraint Analysis
  • Fig. 13 Human Embryonic Stem Cells Market: Porter's analysis
  • Fig. 14 Human Embryonic Stem Cells Market: PESTEL analysis
  • Fig. 15 Human Embryonic Stem Cells Market: Application outlook and key takeaways
  • Fig. 16 Human Embryonic Stem Cells Market: Application market share analysis, 2023 - 2030
  • Fig. 17 Global regenerative medicine market, 2018 - 2030 (USD Million)
  • Fig. 18 Global stem cell biology research market, 2018 - 2030 (USD Million)
  • Fig. 19 Global tissue engineering market, 2018 - 2030 (USD Million)
  • Fig. 20 Global toxicology testing market, 2018 - 2030 (USD Million)
  • Fig. 21 Regional marketplace: Key takeaways
  • Fig. 22 North America Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Canada Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • Fig. 26 Europe Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 UK Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Germany Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Spain Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Italy Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 France Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Denmark Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Sweden Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Norway Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Asia-Pacific Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Japan Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 China Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 India Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 South Korea Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Australia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Thailand Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 LATAM Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Brazil Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Argentina Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 MEA Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Saudi Arabia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 South Africa Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 UAE Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Kuwait Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Key company categorization
  • Fig. 52 Company market positioning
  • Fig. 53 Market Participant categorization
  • Fig. 54 Strategy framework